ArticleDrug design, development and therapy2025

Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial.

Xue-Qi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.